Your browser doesn't support javascript.
A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
Yue, Lei; Xie, Tianhong; Yang, Ting; Zhou, Jian; Chen, Hongbo; Zhu, Hailian; Li, Hua; Xiang, Hong; Wang, Jie; Yang, Huijuan; Zhao, Hong; Wei, Xingchen; Zhang, Yuhao; Xie, Zhongping.
  • Yue L; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Xie T; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Yang T; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Zhou J; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Chen H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Zhu H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Li H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Xiang H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Wang J; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Yang H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Zhao H; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Wei X; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Zhang Y; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Xie Z; Department of Vaccine and Diagnostics, The Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
J Med Virol ; 94(1): 35-38, 2022 01.
Article in English | MEDLINE | ID: covidwho-1404588
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Inactivated / Immunization, Secondary / Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / Antibodies, Viral Topics: Vaccines Limits: Humans Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27334

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Inactivated / Immunization, Secondary / Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / Antibodies, Viral Topics: Vaccines Limits: Humans Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27334